Physician profile
Taylor N Mathews
NPI 1508468323
$2,570.47
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,456 · 2023: $1,115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,069 · Education: $45.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,068.74 |
| Education | $45.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $461.13 | 2022-2023 | Xembify, Prolastin-C Liquid |
| Takeda Pharmaceuticals U.S.A., INC. | $441.41 | 2022-2023 | Glassia, Hyqvia |
| Astrazeneca Pharmaceuticals LP | $262.26 | 2023 | Fasenra, Tezspire |
| Glaxosmithkline, LLC. | $230.21 | 2022-2023 | Nucala, Trelegy Ellipta |
| Pfizer INC. | $192.06 | 2022-2023 | |
| Regeneron Healthcare Solutions, INC. | $175.78 | 2022-2023 | Dupixent |
| Genzyme Corporation | $154.24 | 2022-2023 | |
| Pharming Healthcare, INC. | $123.26 | 2022-2023 | Ruconest |
| Bio Products Laboratory USA, INC. | $86.91 | 2022-2023 | Gammaplex, Coagadex |
| Kaleo, INC. | $53.36 | 2022-2023 | Auvi-Q |
| Baxter Healthcare | $49.07 | 2022-2023 | Hillrom - Vest System Model 105 Home Care |
| Biocryst US Sales Co., LLC | $48.42 | 2022-2023 | Orladeyo |
| Blueprint Medicines Corporation | $44.65 | 2022-2023 | Ayvakit |
| Teva Pharmaceuticals USA, INC. | $44.09 | 2022 | |
| Electromed, INC. | $43.35 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $42.30 | 2022 | |
| Horizon Therapeutics Plc | $26.66 | 2022 | |
| Incyte Corporation | $24.47 | 2022 | |
| Xeris Pharmaceuticals, INC. | $23.26 | 2023 | Gvoke Hypopen |
| Aimmune Therapeutics, INC. | $22.15 | 2022 | |
| Amgen INC. | $21.43 | 2023 | Tezspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Mathews listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.